149 related articles for article (PubMed ID: 22431419)
1. Initiation of sulfonylureas versus metformin is associated with higher blood pressure at one year.
Roumie CL; Liu X; Choma NN; Greevy RA; Hung AM; Grijalva CG; Griffin MR
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):515-23. PubMed ID: 22431419
[TBL] [Abstract][Full Text] [Related]
2. Glycemic and weight changes after persistent use of incident oral diabetes therapy: a Veterans Administration retrospective cohort study.
Huizinga MM; Roumie CL; Greevy RA; Liu X; Murff HJ; Hung AM; Grijalva CG; Griffin MR
Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1108-12. PubMed ID: 20878643
[TBL] [Abstract][Full Text] [Related]
3. The effect of incident antidiabetic regimens on lipid profiles in veterans with type 2 diabetes: a retrospective cohort.
Roumie CL; Huizinga MM; Liu X; Greevy RA; Grijalva CG; Murff HJ; Hung AM; Griffin MR
Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):36-44. PubMed ID: 21182152
[TBL] [Abstract][Full Text] [Related]
4. Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study.
Roumie CL; Min JY; D'Agostino McGowan L; Presley C; Grijalva CG; Hackstadt AJ; Hung AM; Greevy RA; Elasy T; Griffin MR
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28424149
[TBL] [Abstract][Full Text] [Related]
5. Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).
Komajda M; Curtis P; Hanefeld M; Beck-Nielsen H; Pocock SJ; Zambanini A; Jones NP; Gomis R; Home PD;
Cardiovasc Diabetol; 2008 Apr; 7():10. PubMed ID: 18435852
[TBL] [Abstract][Full Text] [Related]
6. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control.
Hung AM; Roumie CL; Greevy RA; Liu X; Grijalva CG; Murff HJ; Griffin MR
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):623-31. PubMed ID: 23592561
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
Roumie CL; Hung AM; Greevy RA; Grijalva CG; Liu X; Murff HJ; Elasy TA; Griffin MR
Ann Intern Med; 2012 Nov; 157(9):601-10. PubMed ID: 23128859
[TBL] [Abstract][Full Text] [Related]
8. Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.
Roumie CL; Greevy RA; Grijalva CG; Hung AM; Liu X; Murff HJ; Elasy TA; Griffin MR
JAMA; 2014 Jun; 311(22):2288-96. PubMed ID: 24915260
[TBL] [Abstract][Full Text] [Related]
9. Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.
Roumie CL; Greevy RA; Grijalva CG; Hung AM; Liu X; Griffin MR
BMC Endocr Disord; 2016 Jun; 16(1):32. PubMed ID: 27255309
[TBL] [Abstract][Full Text] [Related]
10. Quality measure attainment in patients with type 2 diabetes mellitus.
Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Sheng Duh M; Lefebvre P
Am J Manag Care; 2014 Jan; 20(1 Suppl):s5-15. PubMed ID: 24512194
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
[TBL] [Abstract][Full Text] [Related]
12. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.
Lawrence DB; Ragucci KR; Long LB; Parris BS; Helfer LA
J Manag Care Pharm; 2006; 12(6):466-71. PubMed ID: 16925454
[TBL] [Abstract][Full Text] [Related]
13. Association Between Metformin Initiation and Incident Dementia Among African American and White Veterans Health Administration Patients.
Scherrer JF; Morley JE; Salas J; Floyd JS; Farr SA; Dublin S
Ann Fam Med; 2019 Jul; 17(4):352-362. PubMed ID: 31285213
[TBL] [Abstract][Full Text] [Related]
14. Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease.
Marcum ZA; Forsberg CW; Moore KP; de Boer IH; Smith NL; Boyko EJ; Floyd JS
J Gen Intern Med; 2018 Feb; 33(2):155-165. PubMed ID: 29181788
[TBL] [Abstract][Full Text] [Related]
15. Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes.
Gatwood JD; Chisholm-Burns M; Davis R; Thomas F; Potukuchi P; Hung A; Kovesdy CP
J Manag Care Spec Pharm; 2018 Apr; 24(4):379-389. PubMed ID: 29578849
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
17. Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.
Roumie CL; Min JY; Greevy RA; Grijalva CG; Hung AM; Liu X; Elasy T; Griffin MR
CMAJ; 2016 Apr; 188(6):E104-E112. PubMed ID: 26811361
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes: influence of prior antidiabetic drug regimen.
Rendell MS; Glazer NB; Ye Z
J Diabetes Complications; 2003; 17(4):211-7. PubMed ID: 12810245
[TBL] [Abstract][Full Text] [Related]
19. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
[TBL] [Abstract][Full Text] [Related]
20. Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.
Riedel AA; Heien H; Wogen J; Plauschinat CA
Am J Manag Care; 2007 Aug; 13(8):457-63. PubMed ID: 17685826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
